<DOC>
	<DOCNO>NCT02468063</DOCNO>
	<brief_summary>The consecutive patient admit Intensive care unit Hepatology department ILBS full filling eligibility criterion enrol 1:1 ration process randomization.- The study open level study . The investigator strictly follow randomization table give therapy per intervention arm . - Intervention : -the therapeutic intervention vasopressor i.e . noradrenaline alone terlipressin along noradrenaline maintain MAP &gt; 65mm Hg . - Intervention arm - Arm ( A ) - Noradrenaline - Arm ( B ) - Noradrenaline + low dose terlipressin</brief_summary>
	<brief_title>To Assess Efficacy Early Introduction Combination Low Dose Vasopressin Analogue Addition Noradrenaline Vasopressor Patients Cirrhosis With Septic Shock</brief_title>
	<detailed_description />
	<mesh_term>Shock</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Vasopressins</mesh_term>
	<mesh_term>Arginine Vasopressin</mesh_term>
	<mesh_term>Lypressin</mesh_term>
	<mesh_term>Terlipressin</mesh_term>
	<mesh_term>Vasoconstrictor Agents</mesh_term>
	<mesh_term>Norepinephrine</mesh_term>
	<criteria>1870 yr Cirrhosis septic shock respond fluid resuscitation within 2 hr . ECG ( ElectroCardiography ) change presentation exclude use vasopressin analouges Cardiac dysfunction ( valvular heart disease , coronary artery disease ) Acute mesenteric ischemia ( confirm suspect ) vasospastic diathesis ( e.g . Reynaud 's syndrome related disease ) . Pregnancy Acute GI bleed No Consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>